Ozempic (semaglutide) is a diabetes medication that often leads to weight loss as a secondary benefit
After completing starter doses, a weekly maintenance dose of 5mg, 10mg, or 15mg may be given depending on patients needs and response to treatment
Sodium Imbalance in Patients with Acquired HO and Central Diabetes Insipidus Inform patients with diabetes insipidus and their caregivers to contact their healthcare provider if changes in fluid intake or urine output or other signs of dehydration, mental status changes (e.g., confusion, lethargy), or significant nausea and vomiting occur which may require adjustments in concomitant therapies during treatment with IMCIVREE [see Warnings and Precautions (5.6)]
All weight loss medications work best as part of a comprehensive treatment plan that includes a healthy diet, physical activity, and lifestyle changes
Comparative aspects of cortical neurogenesis in vertebrates